Press Releases

Date Title and Summary
Toggle Summary Accuray Incorporated to Speak at UBS Global Life Sciences Conference
SUNNYVALE, Calif., Sept. 16, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the UBS Global Life Sciences Conference in New York on Tuesday, September 20, 2011 at 4:30 p.m.
Toggle Summary Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year 2011
SUNNYVALE, Calif., Sept. 13, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), today announced that it will report results for its fourth quarter and fiscal year 2011, ended June 30, 2011 on Monday, September 19, 2011 after the market closes.
Toggle Summary Growing Clinical Evidence the Focus of Accuray's TomoTherapy Asia User Education Symposium
4th Annual User Meeting Highlights Breadth and Depth of Clinical Applications and Increasing Utilization across Asia SUNNYVALE, Calif., Sept. 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, showcased new clinical research on its
Toggle Summary Accuray Extends Industry-Leading Customer Service Program to TomoTherapy Systems
New TomoTherapy Emerald Service Program Combines Best in Class Product Service Offerings with Guaranteed Uptime for Unparalleled Reliability and Customer Satisfaction SUNNYVALE, Calif., Sept. 6, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology
Toggle Summary Accuray Launches New Organization for CyberKnife® and TomoTherapy® System Users
Accuray Exchange in Radiation Oncology to provide a forum for setting a new standard in patient care SUNNYVALE, Calif., Aug. 31, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the launch of Accuray Exchange in Radiation
Toggle Summary Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
Long Term Clinical Evidence and Worldwide Increase in Patients Treated with the CyberKnife System SUNNYVALE, Calif., Aug. 30, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today a significant increase in use of the CyberKnife®
Toggle Summary Accuray Incorporated to Host Investor Meeting at ASTRO 2011
SUNNYVALE, Calif., Aug. 25, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it will host an investor meeting on Monday, October 3 , at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Miami
Toggle Summary Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System
Premier Teaching Hospital Pioneers Use of Radiosurgery for Patients throughout New England SUNNYVALE, Calif., Aug. 16, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that the Beth Israel Deaconess Medical Center (BIDMC),
Toggle Summary Accuray Incorporated to Speak at 2011 Wedbush Life Sciences: Management Access Conference
SUNNYVALE, Calif., Aug. 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Wedbush Life Sciences: Management Access Conference in New York on Wednesday, August 17, 2011 at
Toggle Summary Accuray Symposium Puts Spotlight on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting
CyberKnife and TomoTherapy Systems Featured in more than 60 Abstracts SUNNYVALE, Calif., July 31, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it will showcase the CyberKnife® Robotic Radiosurgery System and the

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.